Miss a day, miss a lot. Subscribe to The Defender’s Top News of the Day. It’s free.
The authors of a new review of the drug acetaminophen (paracetamol), sold under the brand names Tylenol and Panadol, are sounding the alarm about the use of the drug in infants and children, citing the drug’s association with autism spectrum disorder (ASD).
“Our study shows that acetaminophen would never be approved for pediatric use by today’s regulatory standards,” Dr. William Parker, of WPLab, Inc., who led the research team that conducted the review on acetaminophen and autism, told The Defender.
The review, published in the July issue of Minerva Pediatrics, offers 17 lines of evidence that the commonly used remedy for pain and fever may be contributing to the autism epidemic…